LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About LanZhou Foci Pharmaceutical Co.,Ltd.
—
LanZhou Foci Pharmaceutical Co.,Ltd. is led by CEO Jinfeng Yue, employs 1,332 people, headquartered in Lanzhou, CN, publicly traded since 2011.
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) stock trades at $7.70 with a market capitalization of $4.14B. The stock is valued at a price-to-earnings (P/E) ratio of 73.64, price-to-book of 2.22, price-to-sales of 4.46. Over the past 52 weeks the stock has ranged between $6.63 and $11.02, and currently trades 30.1% below its 52-week high. It pays a dividend yielding 0.25%.
On profitability, LanZhou Foci Pharmaceutical Co.,Ltd. generates a return on equity (ROE) of 2.95%, an operating margin of 5.74%, a net profit margin of 6.35%.
Official website: www.fczy.com
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) — frequently asked questions
What is LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) stock price today?
LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ) is currently trading at $7.70, down 3.51% today.
What is 002644.SZ P/E ratio?
LanZhou Foci Pharmaceutical Co.,Ltd.'s P/E ratio is 73.64. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002644.SZ return on equity (ROE)?
LanZhou Foci Pharmaceutical Co.,Ltd.'s return on equity (ROE) is 2.95%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is LanZhou Foci Pharmaceutical Co.,Ltd.'s market cap?
LanZhou Foci Pharmaceutical Co.,Ltd. has a market capitalization of $4.14B.
Does 002644.SZ pay a dividend?
Yes. LanZhou Foci Pharmaceutical Co.,Ltd. currently yields 0.25%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002644.SZ carry?
LanZhou Foci Pharmaceutical Co.,Ltd. has a debt-to-equity ratio of 0.02. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002644.SZ's profit margin?
LanZhou Foci Pharmaceutical Co.,Ltd. reports a net profit margin of 6.35% — the share of revenue left after every cost, including tax and interest.
What sector is 002644.SZ in?
LanZhou Foci Pharmaceutical Co.,Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002644.SZ listed on?
LanZhou Foci Pharmaceutical Co.,Ltd. trades on SHZ under the ticker 002644.SZ.
What is 002644.SZ's 52-week range?
Over the last year LanZhou Foci Pharmaceutical Co.,Ltd. has traded between $6.63 and $11.02.
Related — Stocks
Popular Stocks
Screens 002644.SZ currently matches
On the figures above, LanZhou Foci Pharmaceutical Co.,Ltd. passes the filters for 10 of our ready-made screens, among them Low Debt Stocks, Stocks Under $10, Debt Free Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.